Journals / Zeynep Kamil Tıp Bülteni / 2011 / Cilt: 42 - Sayı: 4

Classification of Neoplastic and Non-neoplastic Cystic Lesions in Ovaries

Overlerde Neoplastik ve Non-neoplastik Kistik Lezyonların Değerlendirilmesi

Pages
151–156
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Laparoscopy has to be preferred first of all for the patients that were supposed to suffer from benign and protection of ovary tissue has to be taken care of with minimal invasive approach.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Classification of Neoplastic and Non-neoplastic Cystic Lesions in Ovaries Purpose: Determination of the rates of neoplastic and non-neoplastic lesions in ovary cyst cases having been operated.
📊
Key Findings & Data:Material and methods: Files of 126 patients being operated with pre-diagnosis of cystic mass in ovary in obstetrics and gynecology service of our hospital between 2005 and 2010 were inspected retrospectively.
💡
Conclusion & Impact:Laparoscopy has to be preferred first of all for the patients that were supposed to suffer from benign and protection of ovary tissue has to be taken care of with minimal invasive approach.
🔬Design:Research Article
📍Scope:2005 Verileri
⚙️Variables:Domain Parameters

Abstract

Classification of Neoplastic and Non-neoplastic Cystic Lesions in Ovaries Purpose: Determination of the rates of neoplastic and non-neoplastic lesions in ovary cyst cases having been operated. Material and methods: Files of 126 patients being operated with pre-diagnosis of cystic mass in ovary in obstetrics and gynecology service of our hospital between 2005 and 2010 were inspected retrospectively. Findings: TNon-neoplastic cysts in 41 patients (32,5%) and neoplastic tumors in 85 patients (67,4%) were observed out of ovarian masses. 74 benign (58,7%), 3 borderline(2,4%) and 8 malign tumors (6,3%) were observed in neoplastic tumors. All malign ovary tumors cases were operated in elective conditions using laparoscopy. While the average age of patients having these problems was 46±13, average cyst diameter was measured as 18±7.9 cm. 75% of malignancy was resulted from right ovary. The average Ca-125 value was 1420 ± 2079. Discussion: 91 % of cystic masses resulting from ovary were detected as benign in histopathological inspection. Each case has to be evaluated considering ultrasonography, age, tumor determinant and operated in elective conditions if possible. Laparoscopy has to be preferred first of all for the patients that were supposed to suffer from benign and protection of ovary tissue has to be taken care of with minimal invasive approach.

Özet

Amaç: Opere edilmiş over kist olgularında Neoplastik ve non- neoplastik lezyonların oranlarının belirlenmesini amaçladık. Gereç ve yöntemler: Ocak 2005 ile Nisan 2011 tarihleri arasında eleHastanemiz Kadın Hastalıkları ve Doğum servisinde2005 -2010 tarihleri arasında overde kistik kitle ön tanısıyla opere olmuş 126 hastanın dosyaları retrospektif olarak incelendi. Bulgular: Overyan kitleler içerisinde 41 hastada non- neoplastik kistler(%32,5) ve 85 hastada neoplastik tümorler (%67,4) izlenmiştir. Neoplastik tümörler içerisinde 74 benign (%58,7), 3 borderline(%2,4) ve 8 malign tümör (%6,3) izlenmiştir. Tüm malign over tümörlü olgular elektif şartlarda ve laparatomi ile opere edilmişlerdir. Ortalama görülme yaşı 46±13 iken, kist çapı ise 18±7.9 cm olarak ölçülmüştür. % 75 oranında malignite sağ over kaynaklıdır. Ortalama Ca-125 değeri 1.420 ± 2.079 idi. Tartışma: Over kaynaklı kistik kitlelerin % 91’i patolojik olarak bening olarak saptanmıştır. Her bir olgu ultrasonografi, yaş, tümör belirteçleri ile klinik olarak değerlendirilmeli ve mümkünse elektif şartlarda opere edilmelidir. Bening olduğu düşünülen hastalarda öncelikli olarak laparoskopi tercih edilmeli ve minimal invaziv yaklaşımla over dokusunun korunmasına özen gösterilmelidir.

🔖

Cite This Article

ŞİLFELER, D. B., GÜNGÖREN, A., DOLAPÇIOĞLU, S. K., TURHAN, E., HAKVERDİ, S., ERDEM, D., HAKVERDİ, A. U., BALOĞLU, A. (2011). Classification of Neoplastic and Non-neoplastic Cystic Lesions in Ovaries. Zeynep Kamil Tıp Bülteni, Cilt: 42 - Sayı: 4, 151–156. https://ajindex.com/articles/335334

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Imaoka I, Wada A, Kaji Y, Hayashi T, Hayashi M, Matsuo M, Sugimura K. Developing an MR Imaging Strategy for Diagnosis of Ovarian Masses. Radiographics, 2006;26(5):1431-48
  2. Sutton CL, McKinney CD, Jones JE, Gay SB. Ovarian Masses Revisited:Radiologic and Pathologic Correlation. Radiographics. 1992;12(5):853-77
  3. Akercan F, Cirpan T, Yildiz PS, Ozsener S, Karadadas N, Ulukis M. Approaches To The Dıagnosıs And Treatment Of Benign Adnexial Masses. Ege Tıp Dergisi 2005;44(3):151- 54 4) Guerriero S, Ajossa S, Garau N, Piras B, Paoletti AM, Melis GB.Ultrasonography and color Doppler-based triage for adnexal masses to provide the most appropriate surgical approach. Am J Obstet Gynecol. 2005;192(2):401-6
  4. Timmerman D, Verrelst H, Collins WP, Bourne TH, Vergote I. Re: Mol et al. Distinguishing the benign and malignant adnexial mass: an external validation of prognostic models. Gynecol Oncol 2001;83(1):166-8 6) Morgan A. Adnexial mass evaluation in the emergency department. Emerg Med Clin North Am 2001;19(3):799-816 7) Clement PB. Nonneoplastic lesions of the ovary. In: Kurman RJ, ed. Blaustein’s pathology of the female genital tract. 5th ed. New York, NY: Springer-Verlag, 2002;675–727
  5. Hillard PA. Kadın Genital Traktus Benign Hastalıkları: Semptom ve Bulgular. Berek JS, Adashi EY, Hillard PA(eds). Novak Jinekoloji, 12. Baskı. Cev. Editoru: Erk A. İstanbul: Nobel Tıp Kitabevi, 1998;331-97
  6. Koonings PP, Campbell K, Mishell DR Jr, Grimes DA. Relative frequency of primary ovarian neoplasms: a 10 year review. Obstet Gynecol 1989;74:921-6
  7. Gershenson DM. Clinical management potential tumours of low malignancy. Best Pract Res Clin Obslet Gynaecol 2002;16:513-27
  8. Herbst AL. The epidemiology of ovarian carcinoma and the current status of tumor markers to detect disease. Am J Obstet Gynecol 1994;170:1099-105
  9. Berchuck A, Schildkraut JM, Marks JR, Futreal PA. Managing hereditary ovarian cancer risk. Cancer, 1999;86:2517-24
  10. Horner MJ, Ries LAG, Krapcho M, et al. SEER cancer statistics review, 1975–2006, National Cancer Institute. SEER Website. http://seer. cancer.gov/csr/1975_2006 Based on November 2008 SEER data submission. Published May 29, 2009. Accessed December 3, 2009 14) Timor-Trish IE, Lerner JP, Monteagudo A, Santos R. Transvaginal ultrasonographic characterization of ovarian masses by means of colorflow-directed Doppler measurements and a morphologic scoring system. Am J Obstet Gynecol 1993;168:909–13 15) Lerner JP, Timor-Trish LE, Fe